OptimizeRx Corp
OPRX
View Detailed Chart
10.890USD
+0.350+3.32%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
202.47MMarket Cap
2520.83P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+3.32%
5 Days
+1.21%
1 Month
-18.24%
6 Months
-12.74%
Year to Date
-11.17%
1 Year
+97.64%
View Detailed Chart
TradingKey Stock Score of OptimizeRx Corp
Currency: USD Updated: 2026-02-06Key Insights
OptimizeRx Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 66 out of 482 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 24.33.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
OptimizeRx Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
OptimizeRx Corp Highlights
StrengthsRisks
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 47.52% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 92.13M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 92.13M.
Overvalued
The company’s latest PE is 2520.83, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 14.19M shares, decreasing 30.07% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 1.73K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.89.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
24.333
Target Price
+130.87%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
OptimizeRx Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
OptimizeRx Corp Info
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
Ticker SymbolOPRX
CompanyOptimizeRx Corp
CEOSilvestro (Stephen L)
Websitehttps://www.optimizerx.com/
Related Instruments
-2.48%
-2.53%
+1.90%
-1.31%
+0.74%
-0.57%
+4.65%
+3.01%
+1.64%
+4.53%
+3.03%
+3.00%
+0.73%
-0.59%
+3.65%
+3.01%
+0.73%
+8.39%
-0.37%
+2.94%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
67770.850
-2199.280 (-3.14%)
282.580
+22.390 (+8.61%)
2006.820
-44.910 (-2.19%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
